Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary

Ironwood Pharmaceuticals

06/08/2026 14:32

Ironwood Pharmaceuticals, Inc. IRWD.OQ reported quarterly adjusted earnings of 31 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 14 cents.  The mean expectation of four analysts for the quarter was for earnings of 36 cents per share. Wall Street expected results to range from 27 cents to 44 cents per share.
Revenue rose 32.6% to $113.04 million from a year ago; analysts expected $114.84 million. 
Ironwood Pharmaceuticals, Inc.'s reported EPS for the quarter was 31 cents​.
The company reported quarterly net income of $51.29 million.
Ironwood Pharmaceuticals, Inc. shares had fallen by 1.4% this quarter and gained 23.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 10.1% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for Ironwood Pharmaceuticals, Inc. is $5.35, about 22.4% above its last closing price of $4.15
This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.36
0.31
Missed
Mar. 31 2026 
0.24
0.24
Met
Dec. 31 2025 
0.01
-0.01
Missed
Sep. 30 2025 
0.10
0.24
Beat